BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

US SEC Filings Daily Market Digest β€” January 05, 2026

Daily USA Market Intelligence

89 high priority109 medium priority198 total filings analysed

Executive Summary

On January 6, 2026, 198 SEC 8-K filings revealed a surge in material definitive agreements (Item 1.01), financial obligations (Item 2.03), and unregistered equity sales (Item 3.02), indicating widespread capital raising amid neutral sentiment across mostly small-cap and biotech firms. Officer changes (Item 5.02) were prevalent, signaling routine governance adjustments, while rare delistings added bearish notes; overall low materiality and lack of quantitative details suggest a quiet trading day with limited immediate market impact. Portfolio managers should monitor for dilution risks and potential M&A catalysts in biotech/energy sectors, as cross-filing patterns point to liquidity-seeking behavior rather than systemic distress.

Tracking the trend? Catch up on the prior US SEC Filings Daily Market Digest digest from January 04, 2026.

Investment Signals(4)

  • β–²

    Multiple delistings including Compass Diversified, Immunic, and Barinthus [BEARISH] - High materiality events signaling listing failures and potential liquidity crunches

  • β–²

    Clusters of material agreements and M&A completions (e.g., Pixelworks, Day One Biopharma, One Stop Systems) [BULLISH] - Suggest strategic growth opportunities if exhibits reveal favorable terms

  • β–²

    Prevalent unregistered equity sales across 20+ filings (e.g., TPG, KALA BIO) [BEARISH] - Cumulative dilution risk for small-cap holders

  • β–²

    SPAC merger announcements (Athena Tech, Alussa Energy) [BULLISH] - De-SPAC potential in tech/energy amid quiet markets

Risk Flags(4)

  • β–Ό

    Wave of delistings (Compass Diversified, Immunic, Barinthus) and near-delisting signals (Mersana restructuring) - Sector contagion risk in biotech/small caps

  • β–Ό

    Rampant unregistered equity sales and new financial obligations (50+ filings) - Broad dilution and leverage buildup without disclosed terms

  • β–Ό

    Auditor changes (Kun Peng, NUSATRIP, Society Pass, Laser Photonics) - Potential accounting irregularities or control weaknesses

  • β–Ό

    Sparse details across filings - Heightened uncertainty and possible undisclosed adverse events

Opportunities(4)

  • β—†

    Biotech M&A/partnerships (Geron, IGC Pharma, Cyclerion) - Alpha from clinical/strategic catalysts post-agreement scrutiny

  • β—†

    Energy sector financings (Sunrun, Energy Transfer, Trinity Industries) - Position for infrastructure deals amid energy transition

  • β—†

    SPAC de-merger unlocks (Alussa Energy, Compass Digital) - Arbitrage on redemption risks if targets strong

  • β—†

    Post-officer change stability plays - Monitor leadership refreshes in high-turnover firms for turnaround potential

Sector Themes(3)

  • Biotech/Pharma dominance (40+ filings
    β—†

    Geron, Alkermes, Apogee, etc.) - Heavy Reg FD disclosures and agreements signal pipeline funding amid R&D pressures

  • β—†

    Capital markets stress in small caps/SPACs - Frequent equity sales, obligations, and M&A hint at liquidity crunch and consolidation

  • β—†

    Governance churn across sectors - 30+ officer changes reflect board refreshes, potentially stabilizing amid economic uncertainty

Watch List(4)

  • πŸ‘

    Compass Diversified, Immunic, Barinthus - Delisting trajectories for short/avoidance

  • πŸ‘

    Mersana Therapeutics - High-materiality restructuring (change of control, delisting risk)

  • πŸ‘

    Biotech cluster (Geron, Day One, Mersana) - Exhibit details for M&A alpha

  • πŸ‘

    Auditor changers (Society Pass, Laser Photonics) - Governance red flags for deeper diligence

Filing Analyses(198)
Marblegate Capital Corp8-Kneutralmateriality 7/10

06-01-2026

Marblegate Capital Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003211, Size: 7 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing signaling a potentially significant agreement and financial obligation.

UMH PROPERTIES, INC.8-Kneutralmateriality 3/10

06-01-2026

UMH Properties, Inc. filed a general filing (8-K) on January 6, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or quantitative data are specified in the provided information. All specific impacts and numbers are NOT_DISCLOSED.

GERON CORP8-Kneutralmateriality 7/10

06-01-2026

Geron Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003388), reporting under Item 1.01 entry into a material definitive agreement. No details on the agreement's terms, parties, value, or strategic context are disclosed in the provided filing summary. Sector is not specified.

Jackson Financial Inc.8-Kneutralmateriality 5/10

06-01-2026

Jackson Financial Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-000968, Size: 3 MB), reporting under Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific transaction values, share counts, financial metrics, or other numerical details disclosed in the provided information. All quantitative data such as dollar values or percentages is NOT_DISCLOSED.

Calumet, Inc. /DE8-Kneutralmateriality 3/10

06-01-2026

Calumet, Inc. (/DE) filed Form 8-K on January 06, 2026 (AccNo: 0001193125-26-003207, Size: 206 KB) under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, percentages, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

Unknown8-Kneutralmateriality 1/10

06-01-2026

Company filed a Form 8-K on 2026-01-06 (AccNo: 0001193125-26-003148, Size: 244 KB) as a General Filing from us_sec, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, financial statements, exhibits, company name, or sector are disclosed in the provided filing information. Event Type: General Filing.

Athena Technology Acquisition Corp. II8-Kneutralmateriality 2/10

06-01-2026

Athena Technology Acquisition Corp. II filed an 8-K on January 6, 2026 (AccNo: 0001213900-26-001373), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on merger/acquisition structure, parties, valuation, terms, or financial metrics are disclosed in the provided filing summary. Sector not specified; all deal-related information is NOT_DISCLOSED.

STEEL DYNAMICS INC8-Kneutralmateriality 2/10

06-01-2026

Steel Dynamics Inc filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-000833, Size: 253 KB) under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). This is a general filing from the US SEC with no sector specified. No specific details on the Regulation FD disclosure content or exhibits are provided in the filing summary.

Twenty One Capital, Inc.8-Kneutralmateriality 4/10

06-01-2026

Twenty One Capital, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001442, Size: 196 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. Item 9.01 includes financial statements and exhibits. No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative data are provided in the summary.

IGC Pharma, Inc.8-Kneutralmateriality 7/10

06-01-2026

IGC Pharma, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001185185-26-000032, size: 305 KB) reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. Sector not specified. No details on the agreement, transaction value, or other specifics provided.

AMERICAN REBEL HOLDINGS INC8-Kneutralmateriality 7/10

06-01-2026

AMERICAN REBEL HOLDINGS INC filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000461, Size: 586 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or counterparties disclosed in the provided information. Core event involves a material agreement creating financial obligations and equity sales.

NEWS CORP8-Kneutralmateriality 3/10

06-01-2026

News Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001564708-26-000003, Size: 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the financial statements and exhibits are provided in the filing summary. Sector is not specified.

Alussa Energy Acquisition Corp. II8-Kneutralmateriality 3/10

06-01-2026

Alussa Energy Acquisition Corp. II filed an 8-K on January 6, 2026 (AccNo: 0001213900-26-001319, Size: 265 KB) under Items 8.01 Other Events and 9.01 Financial Statements and Exhibits, announcing a Merger/Acquisition event. No specific details on parties, structure, valuation, or financial metrics are disclosed in the provided filing summary. Sector is not specified.

TPG Inc.8-Kneutralmateriality 5/10

06-01-2026

TPG Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003402, Size: 7 MB), reporting Items 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided summary. Core event involves unregistered equity sales and Regulation FD disclosure.

American Drive Acquisition Co8-K/Aneutralmateriality 1/10

06-01-2026

American Drive Acquisition Co filed an 8-K on 2026-01-06 (AccNo: 0001104659-26-000809, Size: 420 KB) under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific details on deal structure, parties, valuation, or financial metrics are disclosed in the provided filing summary. Sector is not specified.

Kyndryl Holdings, Inc.8-Kneutralmateriality 3/10

06-01-2026

Kyndryl Holdings, Inc. filed an 8-K on January 06, 2026 (AccNo: 0001104659-26-001053, Size: 185 KB) disclosing Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer involved, position affected, reason for change, or any numerical data are provided in the available information. Sector is not specified.

Compass Diversified Holdings8-Kbearishmateriality 9/10

06-01-2026

Compass Diversified Holdings filed a Form 8-K on January 6, 2026 (AccNo: 0001345126-26-000005, Size: 238 KB), reporting a delisting-related event under Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing) and Item 9.01 (Financial Statements and Exhibits). No specific details on the delisting reasons, transaction values, financial impacts, or other quantitative metrics are disclosed. Sector is not specified.

FIDELITY D & D BANCORP INC8-Kneutralmateriality 3/10

06-01-2026

Fidelity D & D Bancorp Inc filed a Form 8-K on 2026-01-06 (AccNo: 0001437749-26-000408, Size: 178 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Event occurred on January 06, 2026. No specific details on officer name, position, appointment/resignation, reason, or quantitative data provided.

SmartKem, Inc.8-Kneutralmateriality 1/10

06-01-2026

SmartKem, Inc. filed a Form 8-K on January 6, 2026, under Item 8.01 Other Events. Accession Number: 0001104659-26-001067; File Size: 191 KB. No details on the specific event, transaction, or financial impacts are disclosed.

Abpro Holdings, Inc.8-Kneutralmateriality 3/10

06-01-2026

Abpro Holdings, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001570, Size: 274 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, or financial metrics are disclosed in the provided filing summary. Sector not specified.

Alkermes plc.8-Kneutralmateriality 5/10

06-01-2026

Alkermes plc filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003453), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with a file size of 204 KB; sector not specified. No core event details, transaction values, financial metrics, or named entities beyond the filer are explicitly stated.

Genprex, Inc.8-Kneutralmateriality 2/10

06-01-2026

Genprex, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001437749-26-000437, Size: 173 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, or exhibits content are provided in the filing summary. Sector not specified.

FRACTYL HEALTH, INC.8-Kneutralmateriality 4/10

06-01-2026

FRACTYL HEALTH, INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003452, Size: 632 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position (e.g., CEO, CFO), appointment or resignation status, reasons for change, board impacts, or quantitative data such as transaction values, share counts, or financial metrics are disclosed in the provided filing summary. All leadership, governance, succession, and market impact details are NOT_DISCLOSED.

D-Wave Quantum Inc.8-Kneutralmateriality 5/10

06-01-2026

D-Wave Quantum Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001907982-26-000005, Size: 158 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for Regulation FD updates, with no core event, transaction details, or financial metrics specified. Sector not specified.

TRINITY INDUSTRIES INC8-Kneutralmateriality 7/10

06-01-2026

Trinity Industries Inc filed a Form 8-K on January 6, 2026 (AccNo: 0000099780-26-000006, Size: 702 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, disclosures, transaction value, or financial impacts provided in the summary. All quantitative data, named entities beyond the filer, and event specifics are NOT_DISCLOSED.

ALUMIS INC.8-Kneutralmateriality 2/10

06-01-2026

ALUMIS INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001073, Size: 14 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

Apogee Therapeutics, Inc.8-Kneutralmateriality 3/10

06-01-2026

Apogee Therapeutics, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001063, Size: 5 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financials, or other content are disclosed in the provided filing summary.

Sunrun Inc.8-Kneutralmateriality 7/10

06-01-2026

Sunrun Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001193125-26-003449, Size: 1 MB), disclosing under Item 1.01 entry into a Material Definitive Agreement and under Item 2.03 creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. Item 9.01 includes Financial Statements and Exhibits. No transaction details, dollar values, or other quantitative data are provided in the filing summary.

Energy Transfer LP8-Kneutralmateriality 5/10

06-01-2026

Energy Transfer LP filed a Form 8-K on January 06, 2026 (AccNo: 0001193125-26-003456, Size: 204 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or other specifics are disclosed in the provided filing summary. This appears to be a voluntary disclosure of material nonpublic information with attached exhibits.

ANGIODYNAMICS INC8-Kneutralmateriality 5/10

06-01-2026

AngioDynamics Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001140361-26-000341), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific quantitative data, transaction details, or financial metrics are mentioned in the provided filing information.

McGraw Hill, Inc.8-Kneutralmateriality 2/10

06-01-2026

McGraw Hill, Inc. filed a Form 8-K on 2026-01-06 (AccNo: 0001193125-26-003463, Size: 420 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with additional Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data are provided in the filing summary. Sector is not specified.

Sunoco LP8-Kneutralmateriality 5/10

06-01-2026

Sunoco LP filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003460, Size: 166 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the disclosure, transaction, financials, or exhibits are provided in the filing summary. Sector not specified.

Aclaris Therapeutics, Inc.8-Kneutralmateriality 5/10

06-01-2026

Aclaris Therapeutics, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001076, Size: 5 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the core events, transactions, financial impacts, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

KALA BIO, Inc.8-Kneutralmateriality 7/10

06-01-2026

KALA BIO, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001829126-26-000055), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, or numerical data disclosed in the provided summary. Sector is not specified.

REALTY INCOME CORP8-Kneutralmateriality 3/10

06-01-2026

Realty Income Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001089, Size: 369 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

Six Flags Entertainment Corporation/NEW8-Kneutralmateriality 3/10

06-01-2026

Six Flags Entertainment Corporation filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003472, Size: 268 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the core events, transactions, financial impacts, or quantitative data are disclosed in the provided filing summary. This is a multi-item general filing from the US SEC.

Energy Vault Holdings, Inc.8-Kneutralmateriality 5/10

06-01-2026

Energy Vault Holdings, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001828536-26-000003, Size: 265 KB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or quantitative data are mentioned in the provided filing summary.

Transcode Therapeutics, Inc.8-Kneutralmateriality 3/10

06-01-2026

Transcode Therapeutics, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001097, Size: 210 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure under Regulation FD, with no core event, transaction details, financial metrics, or named entities beyond the filer specified in the filing metadata. Sector is not specified.

REPLIGEN CORP8-Kneutralmateriality 4/10

06-01-2026

REPLIGEN CORP filed an 8-K on January 6, 2026 (AccNo: 0001193125-26-003467), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, reason for change, appointment/resignation status, or any quantitative data provided in the filing summary. Sector not specified.

Milestone Pharmaceuticals Inc.8-Kneutralmateriality 2/10

06-01-2026

Milestone Pharmaceuticals Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001099, Size: 214 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative financial data, transaction values, and strategic impacts are NOT_DISCLOSED.

Edible Garden AG Inc8-Kneutralmateriality 3/10

06-01-2026

Edible Garden AG Inc filed a Form 8-K on January 6, 2026 (AccNo: 0001477932-26-000041, size: 187 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. This appears to be a standard financial results disclosure.

Archrock, Inc.8-Kneutralmateriality 3/10

06-01-2026

Archrock, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001091, Size: 267 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the Regulation FD disclosure content or exhibits are provided. Sector is not specified.

Compass Digital Acquisition Corp.8-Kneutralmateriality 3/10

06-01-2026

Compass Digital Acquisition Corp. filed an 8-K on January 6, 2026 (AccNo: 0001493152-26-000508, Size: 25 MB), disclosing a Merger/Acquisition event under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, or financial metrics are provided in the filing summary. Sector is not specified.

Mineralys Therapeutics, Inc.8-Kneutralmateriality 5/10

06-01-2026

Mineralys Therapeutics, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001933414-26-000002, Size: 173 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with no specific event details, transaction values, or financial metrics disclosed in the summary. Sector is not specified.

HALLADOR ENERGY CO8-Kneutralmateriality 4/10

06-01-2026

HALLADOR ENERGY CO filed a Form 8-K on 2026-01-06 (AccNo: 0001104659-26-001098, Size: 191 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or timing are provided. Event classified as Officer Change; sector not specified.

Denali Therapeutics Inc.8-Kneutralmateriality 3/10

06-01-2026

Denali Therapeutics Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001714899-26-000004, Size: 242 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary. Sector not specified.

Ainos, Inc.8-Kneutralmateriality 3/10

06-01-2026

Ainos, Inc. filed a Form 8-K on January 06, 2026, under Item 8.01 Other Events. Accession number: 0001493152-26-000517; file size: 244 KB. No details on the specific event, transaction, financials, or other quantitative data are provided.

XBP Global Holdings, Inc.8-Kneutralmateriality 2/10

06-01-2026

XBP Global Holdings, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001093, Size: 213 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.

Installed Building Products, Inc.8-Kneutralmateriality 4/10

06-01-2026

Installed Building Products, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001628280-26-000785, Size: 249 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on the core event, transaction values, financial impacts, or other specifics are disclosed in the provided filing summary. This appears to be a multi-item filing involving Regulation FD compliance and attached exhibits.

Dare Bioscience, Inc.8-Kneutralmateriality 2/10

06-01-2026

Dare Bioscience, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001493152-26-000513, Size: 10 MB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, events, transactions, or financial metrics are provided in the filing summary. Sector not specified.

Athene Holding Ltd.8-Kneutralmateriality 3/10

06-01-2026

Athene Holding Ltd. filed a Form 8-K on January 6, 2026 (AccNo: 0001527469-26-000004, size: 638 KB) reporting under Item 7.01 Regulation FD Disclosure. No details on the core event, transaction, financial impacts, or other specifics are disclosed in the provided filing metadata. Sector not specified.

Compass Therapeutics, Inc.8-Kneutralmateriality 5/10

06-01-2026

Compass Therapeutics, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001171843-26-000083, Size: 232 KB), disclosing Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing related to financial results with no specific revenue, earnings, transaction values, or other quantitative metrics mentioned. Sector is not specified.

Digi Power X Inc.8-Kneutralmateriality 3/10

06-01-2026

Digi Power X Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001580, Size: 234 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary disclosure of material non-public information and attachment of related exhibits. No specific details on the content of the disclosure, exhibits, transaction values, financial metrics, or other quantitative data are provided in the filing summary.

Unknown8-Kneutralmateriality 5/10

06-01-2026

Company filed an 8-K on 2026-01-06 (AccNo: 0001213900-26-001582, Size: 262 KB) reporting Items 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific details on transactions, values, entities, or impacts disclosed. Event type is General Filing from US SEC, sector not specified.

Calumet, Inc. /DE8-Kneutralmateriality 2/10

06-01-2026

Calumet, Inc. (/DE) filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003479, Size: 189 KB), disclosing under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other specifics are provided in the filing summary. Sector is not specified.

NORTECH SYSTEMS INC8-Kneutralmateriality 3/10

06-01-2026

NORTECH SYSTEMS INC filed a Form 8-K on 2026-01-06 (AccNo: 0001493152-26-000512, Size: 362 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the filing summary. Sector is not specified.

Earth Science Tech, Inc.8-Kneutralmateriality 2/10

06-01-2026

Earth Science Tech, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000511, size 242 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financial statements, or exhibits are provided. Sector is not specified.

Wheeler Real Estate Investment Trust, Inc.8-Kneutralmateriality 2/10

06-01-2026

Wheeler Real Estate Investment Trust, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001527541-26-000004, Size: 205 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector not specified.

Unknown8-Kneutralmateriality 1/10

06-01-2026

This 8-K general filing, dated January 06, 2026 (AccNo: 0001104659-26-001104, Size: 823 KB), reports Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

Unknown8-Kneutralmateriality 3/10

06-01-2026

The company filed a Form 8-K on January 6, 2026 (AccNo: 0001999784-26-000005, Size: 167 KB), reporting under Item 3.02 an unregistered sale of equity securities. No details on transaction value, share count, parties involved, or financial impact are disclosed in the provided filing summary. This is a single-item general filing with no sector specified.

Cyclerion Therapeutics, Inc.8-Kneutralmateriality 7/10

06-01-2026

Cyclerion Therapeutics, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003509, Size: 8 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with sector not specified. No quantitative data, transaction details, or other specifics disclosed in the provided information.

Silexion Therapeutics Corp8-Kneutralmateriality 5/10

06-01-2026

Silexion Therapeutics Corp filed a Form 8-K on January 06, 2026 (AccNo: 0001178913-26-000067, Size: 283 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or numerical values are explicitly stated in the provided filing summary. This appears to be a multi-item voluntary disclosure related to Regulation FD.

MOBIX LABS, INC8-Kneutralmateriality 3/10

06-01-2026

MOBIX LABS, INC filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000515, Size: 329 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative data including transaction values, share counts, percentages, and financial metrics are NOT_DISCLOSED.

Galecto, Inc.8-Kneutralmateriality 4/10

06-01-2026

Galecto, Inc. filed a Form 8-K on 2026-01-06 (AccNo: 0001193125-26-003490, Size: 485 KB) disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 3.02 (Unregistered Sales of Equity Securities) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer position, name, appointment/resignation status, reasons, or quantitative data such as share counts or transaction values are provided. Sector is not specified.

Aspire Biopharma Holdings, Inc.8-Kneutralmateriality 6/10

06-01-2026

Aspire Biopharma Holdings, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000518, Size: 447 KB), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific details on the agreement, transaction value, share count, or parties provided in the summary. All financial metrics, dollar values, and quantitative impacts are NOT_DISCLOSED.

ATOSSA THERAPEUTICS, INC.8-Kneutralmateriality 2/10

06-01-2026

Atossa Therapeutics, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003506, Size: 209 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial statements, exhibits, transactions, or quantitative data are disclosed in the provided filing summary. This is a multi-item filing with limited information available.

eHealth, Inc.8-Kneutralmateriality 7/10

06-01-2026

eHealth, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001333493-26-000003), reporting multiple events including entry into (Item 1.01) and termination of (Item 1.02) material definitive agreements, creation of a direct financial obligation (Item 2.03), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, or numerical data disclosed. Core events suggest significant corporate restructuring, but all key metrics are NOT_DISCLOSED.

SS Innovations International, Inc.8-Kneutralmateriality 3/10

06-01-2026

SS Innovations International, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001213900-26-001594, Size: 227 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Sector is not specified. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary.

ESS Tech, Inc.8-Kneutralmateriality 3/10

06-01-2026

ESS Tech, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001819438-26-000003, Size: 239 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason, or compensatory arrangements are provided in the filing summary. Sector not specified.

STAAR SURGICAL CO8-Kneutralmateriality 3/10

06-01-2026

STAAR Surgical Co filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003534, Size: 151 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

LifeMD, Inc.8-Kneutralmateriality 7/10

06-01-2026

LifeMD, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000525, Size: 2 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, or other numerical data disclosed in the provided information. Sector is not specified.

LANTRONIX INC8-Kneutralmateriality 3/10

06-01-2026

Lantronix Inc. filed an 8-K on January 6, 2026 (AccNo: 0001683168-26-000113, Size: 204 KB) disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. Specific details including key position affected, appointment/resignation status, reasons, names, or quantitative data are NOT_DISCLOSED.

FORD MOTOR CO8-Kneutralmateriality 4/10

06-01-2026

Ford Motor Co filed an 8-K on January 6, 2026 (AccNo: 0000037996-26-000002, size 1 MB), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transactions, financial statements, or exhibits are disclosed in the provided summary. Sector not specified.

Kun Peng International Ltd.8-Kneutralmateriality 5/10

06-01-2026

Kun Peng International Ltd. filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000521), reporting under Item 4.01 a change in its certifying accountant. No details on the previous or new accountant, reasons for the change, financial impacts, or transaction values are disclosed in the provided filing summary. This is a single-item mandatory disclosure with no quantitative data available.

Unknown8-Kneutralmateriality 6/10

06-01-2026

The registrant filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003552, Size: 202 KB), reporting under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement via a Credit Agreement. Item 9.01 discloses financial statements and exhibits. No specific terms, amounts, counterparties, or company name are mentioned in the provided filing information.

Unknown8-Kneutralmateriality 6/10

06-01-2026

The registrant filed a Form 8-K on January 6, 2026 (AccNo: 0001331757-26-000004, 207 KB) under Item 2.03 disclosing the creation of a direct financial obligation or off-balance sheet arrangement via a Credit Agreement dated January 6, 2026. No specific dollar value, terms, or other quantitative details are provided in the filing summary. Event sourced from us_sec with sector not specified.

Ocean Power Technologies, Inc.8-Kneutralmateriality 2/10

06-01-2026

Ocean Power Technologies, Inc. filed a Form 8-K on January 6, 2026, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). The filing has Accession Number 0001493152-26-000524 and a size of 269 KB. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided information.

QHSLab, Inc.8-Kneutralmateriality 3/10

06-01-2026

QHSLab, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000527, Size: 262 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on the content of the Regulation FD disclosure or attached exhibits are provided. Sector is not specified.

MOTORCAR PARTS OF AMERICA INC8-Kneutralmateriality 4/10

06-01-2026

MOTORCAR PARTS OF AMERICA INC filed a Form 8-K on January 6, 2026 (AccNo: 0001140361-26-000345, Size: 165 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on positions, individuals, reasons, or compensation are provided.

Day One Biopharmaceuticals, Inc.8-Kneutralmateriality 8/10

06-01-2026

Day One Biopharmaceuticals, Inc. announced via 8-K filing on January 06, 2026 (AccNo: 0001104659-26-001127, Size: 8 MB), entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No details on parties involved, deal structure, valuation, consideration, or strategic rationale are disclosed in the provided filing summary. Sector is not specified.

Mersana Therapeutics, Inc.8-Kneutralmateriality 9/10

06-01-2026

Mersana Therapeutics, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001125), disclosing termination of a material definitive agreement (Item 1.02), completion of an acquisition or disposition of assets (Item 2.01), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departure/election of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws and change in fiscal year (Item 5.03), and financial statements/exhibits (Item 9.01). The filing signals a major corporate restructuring event, likely a merger or acquisition resulting in change of control and delisting, with no specific parties, valuation, or consideration disclosed. All numerical values, deal terms, and strategic details are NOT_DISCLOSED.

Unknown8-Kneutralmateriality 5/10

06-01-2026

The company filed a Form 8-K on January 6, 2026 (AccNo: 0001331465-26-000004, Size: 183 KB), disclosing under Item 2.03 the creation of a direct financial obligation via a Credit Agreement. No specific dollar values, terms, counterparties, or other quantitative details are provided in the filing summary. Event type is Credit Agreement with sector not specified.

Unknown8-Kneutralmateriality 4/10

06-01-2026

The registrant filed a Form 8-K on January 6, 2026 (AccNo: 0001325878-26-000004, 159 KB) under Item 2.03 disclosing the creation of a direct financial obligation via a Credit Agreement. This is a mandatory disclosure of a new credit facility or similar arrangement. No dollar value, terms, or other financial details are specified in the provided filing summary.

Lottery.com Inc.8-Kneutralmateriality 2/10

06-01-2026

Lottery.com Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000531, Size: 265 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position (e.g., CEO, CFO), person involved, appointment/resignation status, reasons, or timing are disclosed in the provided filing summary. Sector is not specified.

Harvard Apparatus Regenerative Technology, Inc.8-Kneutralmateriality 8/10

06-01-2026

Harvard Apparatus Regenerative Technology, Inc. filed an 8-K on January 06, 2026 (AccNo: 0001437749-26-000452, Size: 341 KB), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing from the US SEC source. No specific transaction details, amounts, or financial metrics are disclosed in the provided summary.

NLIGHT, INC.8-Kneutralmateriality 4/10

06-01-2026

NLIGHT, INC. filed a Form 8-K on 2026-01-06 (AccNo: 0001124796-26-000003, Size: 158 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 includes Financial Statements and Exhibits. No specific details on the officer, position, reason, or quantitative impacts are provided.

Unknown8-Kneutralmateriality 1/10

06-01-2026

This Form 8-K filing under Item 8.01 Other Events was submitted on January 6, 2026, with Accession Number 0001193125-26-003682 and a file size of 146 KB. The event is classified as a General Filing from US SEC source, with no sector specified. No details on the core event, transaction, financial impacts, or other specifics are disclosed.

Unknown8-Kneutralmateriality 4/10

06-01-2026

The registrant filed a Form 8-K on 2026-01-06 (AccNo: 0001331451-26-000002, Size: 171 KB) under Item 2.03 disclosing the creation of a direct financial obligation via a Credit Agreement dated January 06, 2026. Event type is Credit Agreement; sector not specified. No transaction value, terms, counterparties, or other financial details are mentioned in the provided filing excerpt.

CHOICE HOTELS INTERNATIONAL INC /DE8-Kneutralmateriality 2/10

06-01-2026

Choice Hotels International Inc./DE filed a Form 8-K on January 6, 2026 (AccNo: 0001628280-26-000795, Size: 151 KB) disclosing an officer change under Item 5.02. The item covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions, reasons, or financial details are provided in the summary.

Unknown8-Kneutralmateriality 4/10

06-01-2026

The company filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003792, Size: 186 KB), disclosing unregistered sales of equity securities under Item 3.02. No details on transaction value, share count, parties involved, or financial impacts are provided. This is classified as a General Filing event from us_sec source.

BELDEN INC.8-Kneutralmateriality 3/10

06-01-2026

Belden Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0000913142-26-000003, Size: 146 KB) disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on affected officers, positions, reasons, or compensatory arrangements are provided. Sector not specified.

Unknown8-Kneutralmateriality 4/10

06-01-2026

The company filed a Form 8-K on January 6, 2026 (AccNo: 0002071136-26-000003), reporting unregistered sales of equity securities under Item 3.02 and financial statements and exhibits under Item 9.01. No specific details on transaction value, share count, parties involved, or financial impacts are disclosed in the filing summary. This appears to be a mandatory disclosure for a general filing event.

Unknown8-Kneutralmateriality 3/10

06-01-2026

The company filed a Form 8-K on January 6, 2026 (AccNo: 0001580642-26-000076, Size: 193 KB), reporting under Item 3.02 regarding unregistered sales of equity securities. No details on transaction value, share count, parties involved, or financial impacts are disclosed. This appears to be a single-item mandatory disclosure of a general filing event.

Unknown8-Kneutralmateriality 4/10

06-01-2026

The company filed a Form 8-K on 2026-01-06 (AccNo: 0001944366-26-000003, Size: 149 KB) reporting Item 3.02 Unregistered Sales of Equity Securities and Item 8.01 Other Events. No specific details on the sales, events, transaction values, share counts, or other financial metrics are disclosed in the provided filing information. This is a multi-item general filing from an unspecified sector.

TABLE TRAC INC8-Kneutralmateriality 3/10

06-01-2026

Table Trac Inc filed a Form 8-K on January 6, 2026 (AccNo: 0001437749-26-000465, size 152 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment or resignation, reasons, or compensatory arrangements are provided in the summary. Sector is not specified.

Unknown8-Kneutralmateriality 6/10

06-01-2026

The registrant filed an 8-K on 2026-01-06 (AccNo: 0001316944-26-000004, Size: 151 KB) under Item 2.03 disclosing the creation of a direct financial obligation or off-balance sheet arrangement via a Credit Agreement dated January 06, 2026. This is reported as a material event from us_sec source. No specific dollar values, terms, counterparties, or other financial metrics are disclosed in the provided filing summary.

ScanTech AI Systems Inc.8-Kneutralmateriality 6/10

06-01-2026

ScanTech AI Systems Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001227, Size: 240 KB), reporting Items 2.04 (Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Off-Balance Sheet Arrangement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core event, transaction value, or financial impacts provided. Sector not specified.

Unknown8-Kneutralmateriality 3/10

06-01-2026

Company filed an 8-K on January 06, 2026 (AccNo: 0001193125-26-003978, Size: 6 MB) under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a Financial Results event from US SEC source. No specific financial metrics, transaction details, named entities, or quantitative data provided in the filing summary.

SELECTIS HEALTH, INC.8-Kneutralmateriality 3/10

06-01-2026

SELECTIS HEALTH, INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000558, Size: 199 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any compensatory arrangements are provided. Sector is not specified, and no quantitative financial data such as transaction values, share counts, or percentages is mentioned.

AIxCrypto Holdings, Inc.8-Kneutralmateriality 4/10

06-01-2026

AIxCrypto Holdings, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000561, Size: 243 KB), reporting Items 5.07 (Submission of Matters to a Vote of Security Holders), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with no further details provided on vote outcomes, disclosure content, or exhibits. Sector not specified.

Profound Medical Corp.8-Kneutralmateriality 5/10

06-01-2026

Profound Medical Corp. filed a Form 8-K on January 06, 2026 (AccNo: 0001171843-26-000096, Size: 228 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item general filing from the US SEC with sector not specified. No details on the core event, transaction values, financial impacts, or other specifics are disclosed in the provided information.

Unknown8-Kneutralmateriality 1/10

06-01-2026

This Form 8-K filing reports under Item 8.01 Other Events, dated January 06, 2026, with Accession Number 0001193125-26-004066 and file size 208 KB. Event type is listed as General Filing from source us_sec. No specific details on the core event, transaction, financial impacts, or other quantitative data are disclosed.

HOME BANCORP, INC.8-Kneutralmateriality 3/10

06-01-2026

HOME BANCORP, INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001628280-26-000838, Size: 195 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the core event, transactions, financial metrics, or entities are explicitly stated in the provided filing summary.

Unknown8-Kneutralmateriality 7/10

06-01-2026

Company filed 8-K on 2026-01-06 (AccNo: 0001628280-26-000873, Size: 73 MB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item Material Event filing from the US SEC with no specific transaction details, dollar values, parties, or financial metrics disclosed in the provided summary. Sector not specified.

Axos Financial, Inc.8-Kneutralmateriality 1/10

06-01-2026

Axos Financial, Inc. filed a Form 8-K on January 6, 2026, under Item 8.01 Other Events. Accession Number: 0001299709-26-000003, file size: 217 KB. No details on the specific event, transaction, or financial impacts are disclosed.

SolarMax Technology, Inc.8-Kneutralmateriality 6/10

06-01-2026

SolarMax Technology, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001640334-26-000032, Size: 1 MB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing classified as a Material Event, but specific details on the agreement, transaction terms, or disclosures are NOT_DISCLOSED. No quantitative financial data or named entities beyond the filer are provided.

AIR LEASE CORP8-Kneutralmateriality 4/10

06-01-2026

Air Lease Corp filed an 8-K on January 6, 2026 (AccNo: 0001193125-26-004412, Size: 219 KB), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 notes financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are provided.

IMMUNIC, INC.8-Kbearishmateriality 10/10

06-01-2026

Immunic, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193805-26-000011, Size: 188 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This discloses a delisting event from the US market. No additional details on reasons, financial impacts, or transaction values are provided.

CHINA PHARMA HOLDINGS, INC.8-Kneutralmateriality 2/10

06-01-2026

CHINA PHARMA HOLDINGS, INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001785, Size: 200 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. This is a single-item, mandatory disclosure under SEC rules for shareholder meeting results. No specific vote details, proposals, outcomes, or quantitative data are disclosed.

Newton Golf Company, Inc.8-Kneutralmateriality 5/10

06-01-2026

Newton Golf Company, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000591, Size: 234 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

ARROWHEAD PHARMACEUTICALS, INC.8-Kneutralmateriality 3/10

06-01-2026

Arrowhead Pharmaceuticals, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0000879407-26-000004, Size: 8 MB) reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financials, or exhibits are disclosed in the provided filing summary. Sector not specified.

INVO Fertility, Inc.8-Kneutralmateriality 4/10

06-01-2026

INVO Fertility, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000592, Size: 394 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including key position affected, appointment or resignation, reasons, compensation, or any quantitative financial metrics are NOT_DISCLOSED. Event type is Officer Change; sector not specified.

Aimei Health Technology Co., Ltd.8-Kneutralmateriality 7/10

06-01-2026

Aimei Health Technology Co., Ltd. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000589, Size: 322 KB), reporting under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No transaction details, dollar values, or other quantitative data are specified.

OCTAVE SPECIALTY GROUP INC8-Kneutralmateriality 1/10

06-01-2026

OCTAVE SPECIALTY GROUP INC filed a Form 8-K on January 06, 2026 (AccNo: 0001628280-26-000870, Size: 1 MB), reporting under Item 9.01 Financial Statements and Exhibits. No details on the specific financial statements, exhibits, or associated events/transactions are disclosed. Sector not specified.

PennantPark Floating Rate Capital Ltd.8-Kneutralmateriality 3/10

06-01-2026

PennantPark Floating Rate Capital Ltd. filed a Form 8-K on January 06, 2026 (AccNo: 0001171843-26-000103, Size: 225 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a general filing from the US SEC with no further details on the disclosure content provided. Sector not specified.

PENNANTPARK INVESTMENT CORP8-Kneutralmateriality 1/10

06-01-2026

PENNANTPARK INVESTMENT CORP filed a Form 8-K on January 06, 2026 (AccNo: 0001171843-26-000104, Size: 226 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the disclosures, core events, transactions, financial metrics, or named entities are explicitly stated in the filing summary. All quantitative data and specific impacts are NOT_DISCLOSED.

Dror Ortho-Design, Inc.8-Kneutralmateriality 7/10

06-01-2026

Dror Ortho-Design, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001784, size 778 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties, or financial impacts are disclosed in the provided information. Sector is not specified.

CSG SYSTEMS INTERNATIONAL INC8-Kneutralmateriality 0/10

06-01-2026

CSG Systems International Inc filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004380, size: 150 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are provided in the filing summary. Sector not specified.

ELECTRONIC ARTS INC.8-Kbearishmateriality 8/10

06-01-2026

Electronic Arts Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0000712515-26-000002, Size: 145 KB), reporting under Item 1.02 the termination of a material definitive agreement, under Item 2.04 triggering events that accelerate or increase a direct financial obligation or off-balance sheet arrangement, and under Item 8.01 other events. No specific details on the core event, transaction value, parties involved, financial impacts, or timelines are disclosed in the provided filing summary. This is a multi-item filing likely mandatory given the material nature.

COMERICA INC8-Kneutralmateriality 4/10

06-01-2026

Comerica Inc filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004372, size 278 KB), disclosing Items 5.07 (Submission of Matters to a Vote of Security Holders), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details provided on vote results, disclosures, or exhibits. Sector not specified.

Spectral AI, Inc.8-Kneutralmateriality 3/10

06-01-2026

Spectral AI, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001781, Size: 240 KB), disclosing an event under Item 5.02 related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative data are provided in the available filing summary. Sector is not specified.

PIXELWORKS, INC8-Kneutralmateriality 5/10

06-01-2026

Pixelworks, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001040161-26-000002, Size: 173 KB) announcing under Item 2.01 the completion of an acquisition or disposition of assets. The filing also includes Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on parties, deal structure, valuation, or financial impacts are disclosed in the provided summary.

CHS INC8-Kneutralmateriality 2/10

06-01-2026

CHS INC filed a Form 8-K on January 6, 2026 (AccNo: 0000823277-26-000003, Size: 208 KB) reporting under Item 8.01 Other Events. No specific details of the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector is not specified.

PMGC Holdings Inc.8-Kneutralmateriality 6/10

06-01-2026

PMGC Holdings Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001213900-26-001782, Size: 3 MB) as a multi-item disclosure covering Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, transaction values, financial metrics, named entities beyond the filer, or quantitative impacts are disclosed in the provided filing summary. Sector is not specified.

FIFTH THIRD BANCORP8-Kneutralmateriality 3/10

06-01-2026

Fifth Third Bancorp filed an 8-K on January 6, 2026 (AccNo: 0001193125-26-004377, Size: 278 KB), reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing covering shareholder vote results and voluntary Regulation FD disclosure. No financial metrics, transaction details, or quantitative impacts are disclosed.

Flora Growth Corp.8-Kneutralmateriality 3/10

06-01-2026

Flora Growth Corp. disclosed an officer change via Form 8-K filed on January 6, 2026 (AccNo: 0001062993-26-000078, Size: 227 KB), under Item 5.02 covering departures of directors or certain officers, elections or appointments of directors/officers, and compensatory arrangements. No specific details on the affected position, individual names, appointment/resignation status, reasons, or terms are provided. Sector is not specified.

Blend Labs, Inc.8-Kneutralmateriality 4/10

06-01-2026

Blend Labs, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001855747-26-000003, Size: 156 KB) reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on core events, transactions, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure compliant with Regulation FD requirements.

Direct Digital Holdings, Inc.8-Kneutralmateriality 3/10

06-01-2026

Direct Digital Holdings, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001880613-26-000003), reporting an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), submission of matters to a vote of security holders under Item 5.07, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

Estrella Immunopharma, Inc.8-Kneutralmateriality 7/10

06-01-2026

Estrella Immunopharma, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001777, Size: 1 MB), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction terms, parties, values, or financial impacts provided in the summary. Sector is not specified.

HA Sustainable Infrastructure Capital, Inc.8-Kneutralmateriality 1/10

06-01-2026

HA Sustainable Infrastructure Capital, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004493, Size: 144 KB) reporting under Item 9.01 Financial Statements and Exhibits. No specific financial statements, exhibits, transaction details, or numerical values are disclosed in the provided filing summary. Sector is not specified.

MidWestOne Financial Group, Inc.8-Kneutralmateriality 2/10

06-01-2026

MidWestOne Financial Group, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001412665-26-000003, size 145 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific event, transaction, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item filing with limited transparency on content.

Trailblazer Merger Corp I8-Kneutralmateriality 1/10

06-01-2026

Trailblazer Merger Corp I filed an 8-K on January 6, 2026 (AccNo: 0001213900-26-001799, Size: 256 KB) under Item 8.01 Other Events announcing a Merger/Acquisition event. No details on deal structure, parties involved, valuation, consideration, synergies, regulatory pathway, shareholder impact, or market implications are disclosed in the provided filing information. Sector is not specified.

Tradeweb Markets Inc.8-Kneutralmateriality 7/10

06-01-2026

Tradeweb Markets Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001758730-26-000008, Size: 165 KB), reporting under Item 1.01 entry into a material definitive agreement. No details on the agreement's nature, parties, transaction value, or financial terms are disclosed in the provided filing summary. All specific quantitative data and named entities beyond the filer are NOT_DISCLOSED.

NUSATRIP Inc8-Kneutralmateriality 6/10

06-01-2026

NUSATRIP Inc filed an 8-K on January 06, 2026 (AccNo: 0001493152-26-000607, Size: 253 KB), reporting a change in its certifying accountant under Item 4.01 and financial statements and exhibits under Item 9.01. No details on the reasons for the accountant change, financial impacts, or transaction values are disclosed. Sector not specified.

Lifeward Ltd.8-Kneutralmateriality 2/10

06-01-2026

Lifeward Ltd. filed an 8-K on January 6, 2026 (AccNo: 0001178913-26-000081, Size: 184 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on votes, outcomes, proposals, or numerical results are disclosed in the provided filing information. This is a standard mandatory disclosure for shareholder meeting vote results.

BayFirst Financial Corp.8-Kneutralmateriality 7/10

06-01-2026

BayFirst Financial Corp. filed an 8-K on 2026-01-06 (AccNo: 0001649739-26-000003, Size: 183 KB) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, parties, or exhibits provided in the available summary. Sector not specified.

ADIAL PHARMACEUTICALS, INC.8-Kneutralmateriality 4/10

06-01-2026

Adial Pharmaceuticals, Inc. disclosed an officer change via SEC Form 8-K filed on January 6, 2026 (AccNo: 0001213900-26-001790, Size: 187 KB). The filing pertains to Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on individuals, positions, reasons, or compensation are provided in the available information.

Samsara Inc.8-Kneutralmateriality 2/10

06-01-2026

Samsara Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001628280-26-000886, Size: 139 KB), reporting under Item 8.01 Other Events. No specific details on the core event, transaction, financial impacts, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

MV Oil Trust8-Kneutralmateriality 4/10

06-01-2026

MV Oil Trust filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001311, Size: 35 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, revenue, earnings, or other quantitative data are disclosed in the provided filing summary. This is a financial results disclosure for the US market, sector not specified.

Unknown8-Kneutralmateriality 5/10

06-01-2026

The company filed a Form 8-K on 2026-01-06 (AccNo: 0001331463-26-000004, size 170 KB) under Item 2.03, disclosing the creation of a direct financial obligation via a Credit Agreement dated January 06, 2026. This is reported as an event type of Credit Agreement from US SEC source. No transaction value, terms, counterparties, or other financial details are provided in the filing summary.

SOCIETY PASS INCORPORATED.8-Kneutralmateriality 7/10

06-01-2026

Society Pass Incorporated filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000606), reporting changes in its certifying accountant under Item 4.01 and financial statements and exhibits under Item 9.01. No details on the accountants involved, reasons for change, or any quantitative financial impacts are disclosed in the provided filing summary. All specific transaction values, share counts, percentages, and financial metrics are NOT_DISCLOSED.

Penguin Solutions, Inc.8-Kneutralmateriality 3/10

06-01-2026

Penguin Solutions, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001616533-26-000008, size 839 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure with no specific revenue, earnings, or other metrics detailed in the provided information. Sector not specified.

CEA Industries Inc.8-Kneutralmateriality 3/10

06-01-2026

CEA Industries Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000598, size 258 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.

TREDEGAR CORP8-K/Aneutralmateriality 3/10

06-01-2026

Tredegar Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004456, Size: 145 KB), disclosing an Item 5.02 event involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.

REGIONAL HEALTH PROPERTIES, INC8-Kneutralmateriality 3/10

06-01-2026

Regional Health Properties, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004436), reporting under Item 5.07 the submission of matters to a vote of security holders. This is a single-item filing with no additional details on voting matters, outcomes, or numerical data provided in the summary. Item 5.07 disclosures are mandatory for shareholder vote results.

NATIONAL PRESTO INDUSTRIES INC8-Kneutralmateriality 1/10

06-01-2026

NATIONAL PRESTO INDUSTRIES INC filed a Form 8-K on January 06, 2026 (AccNo: 0001437749-26-000614, Size: 165 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

Leonardo DRS, Inc.8-Kneutralmateriality 3/10

06-01-2026

Leonardo DRS, Inc. disclosed an officer change via Form 8-K filed on January 06, 2026 (AccNo: 0001833756-26-000002, Size: 163 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.

MATRIX SERVICE CO8-Kneutralmateriality 2/10

06-01-2026

MATRIX SERVICE CO filed a Form 8-K on January 6, 2026 (AccNo: 0000866273-26-000006, Size: 142 KB), disclosing Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals, reasons for change, or quantitative data are provided. Sector is not specified.

Barinthus Biotherapeutics plc.8-Kbearishmateriality 9/10

06-01-2026

Barinthus Biotherapeutics plc. filed a Form 8-K on January 6, 2026 (AccNo: 0001828185-26-000004, Size: 190 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No details on delisting reasons, transaction values, financial impacts, or related entities are disclosed. Sector is not specified.

Quipt Home Medical Corp.8-Kneutralmateriality 2/10

06-01-2026

Quipt Home Medical Corp. filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001322, Size: 211 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or exhibits are disclosed in the provided filing summary. Sector is not specified.

ONE STOP SYSTEMS, INC.8-Kneutralmateriality 7/10

06-01-2026

One Stop Systems, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001193125-26-004552, Size: 1 MB), disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also includes Regulation FD disclosure (Item 7.01) and financial statements and exhibits (Item 9.01). No specific details on parties, structure, valuation, or financial terms are provided.

GLADSTONE LAND Corp8-Kneutralmateriality 2/10

06-01-2026

Gladstone Land Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004612, Size: 211 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. This appears to be a voluntary multi-item disclosure with no quantified impacts mentioned.

AAR CORP8-Kneutralmateriality 5/10

06-01-2026

AAR CORP filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001328, size: 4 MB), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative details are provided in the filing summary. Sector is not specified.

Praxis Precision Medicines, Inc.8-Kneutralmateriality 3/10

06-01-2026

Praxis Precision Medicines, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001689548-26-000002, Size: 149 KB) under Item 2.02 reporting Results of Operations and Financial Condition. No specific financial metrics, transaction details, revenue, earnings, or quantitative data are disclosed in the provided filing information. Sector is not specified.

Jushi Holdings Inc.8-Kneutralmateriality 3/10

06-01-2026

Jushi Holdings Inc. disclosed an officer change via Form 8-K filed on January 6, 2026 (AccNo: 0001628280-26-000908, Size: 355 KB), under Item 5.02 covering departures of directors or certain officers, elections, appointments, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer, position, nature of change (appointment/resignation), reasons, or quantitative data are provided.

Unknown8-Kneutralmateriality 4/10

06-01-2026

The company filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004530, Size: 127 KB) under Item 3.02 disclosing unregistered sales of equity securities. This is classified as a General Filing event from us_sec source. No specific details on transaction value, share count, parties involved, or financial impacts are provided.

SOUTHSIDE BANCSHARES INC8-Kneutralmateriality 1/10

06-01-2026

Southside Bancshares Inc filed a Form 8-K on January 6, 2026 (AccNo: 0000705432-26-000002, Size: 170 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector not specified.

Unknown8-Kneutralmateriality 7/10

06-01-2026

The company filed an 8-K on January 6, 2026 (AccNo: 0001193125-26-004600) reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, parties involved, or financial metrics are disclosed in the provided filing excerpt. This is a multi-item mandatory material event disclosure.

T-Mobile US, Inc.8-Kneutralmateriality 7/10

06-01-2026

T-Mobile US, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004596, Size: 1 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement, and Item 9.01 Financial Statements and Exhibits. No details on the specific agreement, transaction value, parties involved, or financial terms are disclosed in the provided summary. This is a multi-item mandatory filing likely related to a financing or debt arrangement.

LM FUNDING AMERICA, INC.8-Kneutralmateriality 2/10

06-01-2026

LM Funding America, Inc. filed a Form 8-K on January 6, 2026, reporting under Item 8.01 Other Events. The filing has accession number 0001193125-26-004587 and file size of 162 KB. Sector is not specified, and no details on the event are provided.

TETRA TECH INC8-Kneutralmateriality 3/10

06-01-2026

Tetra Tech Inc filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001352, Size: 222 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), along with Other Events (Item 8.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the officer's name, position, nature of change (appointment or resignation), reasons, or compensation are provided. Sector is not specified.

Awaysis Capital, Inc.8-Kneutralmateriality 3/10

06-01-2026

Awaysis Capital, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000614, Size: 193 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters voted upon, results, or outcomes are disclosed in the provided filing summary. Sector is not specified.

CATERPILLAR INC8-Kneutralmateriality 4/10

06-01-2026

Caterpillar Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001346, Size: 637 KB), disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation, reasons, or quantitative data are disclosed in the provided filing summary. Sector information is not specified.

Mobileye Global Inc.8-Kneutralmateriality 7/10

06-01-2026

Mobileye Global Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001340), disclosing Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), and Financial Statements and Exhibits (Item 9.01). This is a multi-item mandatory filing with no specific details on the agreement, securities sale, transaction value, or financial impacts provided in the available information. Sector not specified.

Oncotelic Therapeutics, Inc.8-Kneutralmateriality 7/10

06-01-2026

Oncotelic Therapeutics, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001493152-26-000613, Size: 208 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, dollar values, or quantitative data disclosed in the provided summary. Sector not specified.

PLUG POWER INC8-Kneutralmateriality 7/10

06-01-2026

PLUG POWER INC filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001336, size 314 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, counterparties, or financial impacts are disclosed in the provided filing summary. Sector not specified.

United Parks & Resorts Inc.8-Kneutralmateriality 2/10

06-01-2026

United Parks & Resorts Inc. disclosed an officer change via Form 8-K filed on 2026-01-06 (AccNo: 0001193125-26-004574, Size: 141 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the affected position, individual names, appointment/resignation status, reasons, or other quantitative data are provided in the filing summary. Sector is not specified.

BECTON DICKINSON & CO8-Kneutralmateriality 2/10

06-01-2026

Becton Dickinson & Co filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004659), reporting under Item 5.04 a temporary suspension of trading under the registrant's employee benefit plans. No details on duration, reasons, financial impact, or transaction sizes are disclosed. This appears to be a compliance-related disclosure with no quantified elements provided.

HUNTINGTON BANCSHARES INC /MD/8-Kneutralmateriality 3/10

06-01-2026

Huntington Bancshares Inc./MD/ filed an 8-K on January 6, 2026 (AccNo: 0001140361-26-000385, Size: 711 KB), reporting Items 5.07 (Submission of Matters to a Vote of Security Holders), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with no specific details on votes, events, or exhibits provided. No quantitative data, transaction values, or named entities beyond the filer are disclosed.

FLOWERS FOODS INC8-Kneutralmateriality 3/10

06-01-2026

Flowers Foods Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004576, Size: 176 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Event type is Officer Change from US SEC source.

SMITH A O CORP8-Kneutralmateriality 6/10

06-01-2026

SMITH A O CORP filed a Form 8-K on January 06, 2026 (AccNo: 0000091142-26-000003, size 33 MB), reporting under Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No details on the specific obligation, events, transaction values, financial impacts, or exhibits are disclosed in the provided filing summary. This is a multi-item mandatory filing as per SEC 8-K requirements.

GLOBAL PARTNERS LP8-Kneutralmateriality 2/10

06-01-2026

GLOBAL PARTNERS LP filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001335, size 369 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, nature of change (appointment or resignation), reasons, or compensation provided in the available information. Sector not specified.

BANK OF AMERICA CORP /DE/8-Kneutralmateriality 5/10

06-01-2026

Bank of America Corp /DE/ filed a General Filing (likely Form 8-K) on January 06, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). Accession Number: 0000070858-26-000011, File Size: 3 MB. No specific event details, financial data, or transaction information disclosed in the provided summary.

POWELL INDUSTRIES INC8-Kneutralmateriality 3/10

06-01-2026

Powell Industries Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0000080420-26-000009, Size: 141 KB), disclosing an officer change under Item 5.02, which pertains to departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. No specific details on the affected officer, position, appointment or resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.

RARE ELEMENT RESOURCES LTD8-Kneutralmateriality 2/10

06-01-2026

Rare Element Resources Ltd filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001387, Size: 218 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.

Unknown8-Kneutralmateriality 1/10

06-01-2026

This Form 8-K filing reports under Item 8.01 Other Events on January 6, 2026, with Accession Number 0001628280-26-000952 and file size of 142 KB. It is classified as a General Filing from the US SEC with no sector specified. No details on the core event, transaction, financial impacts, or other specifics are provided in the filing summary.

VEEA INC.8-Kneutralmateriality 2/10

06-01-2026

VEEA INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001835, size 254 KB), reporting under Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters submitted, vote outcomes, or any numerical data are disclosed in the provided filing summary. Sector is not specified.

Cibus, Inc.8-Kneutralmateriality 2/10

06-01-2026

Cibus, Inc. filed a Form 8-K on January 6, 2026, under Item 8.01 Other Events. Accession Number: 0001628280-26-000957, File Size: 135 KB. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary.

WESTLAKE CORP8-Kneutralmateriality 3/10

06-01-2026

Westlake Corp filed a Form 8-K on January 06, 2026 (AccNo: 0001262823-26-000005, Size: 201 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, events, transactions, or financial data are provided in the filing summary. This appears to be a multi-item filing involving voluntary Regulation FD disclosure with attached exhibits.

MIDDLEBY Corp8-Kneutralmateriality 7/10

06-01-2026

Middleby Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004740, size 160 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, counterparties, transaction value, or financial impacts are disclosed in the provided summary. Sector not specified.

STAAR SURGICAL CO8-Kbearishmateriality 7/10

06-01-2026

STAAR Surgical Co filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004699, size 141 KB), disclosing under Item 1.02 the termination of a material definitive agreement and under Item 5.07 the submission of matters to a vote of security holders. No details on the agreement, vote outcomes, dollar values, or financial impacts are provided in the summary. Sector not specified.

Celanese Corp8-Kneutralmateriality 3/10

06-01-2026

Celanese Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001306830-26-000003, Size: 256 KB), disclosing an officer change under Item 5.02 covering departures of directors or certain officers, elections or appointments of directors or certain officers, and compensatory arrangements. Item 9.01 lists financial statements and exhibits. No specific details on the affected officer, position, reason for change, or quantitative data are provided in the filing summary.

Skyward Specialty Insurance Group, Inc.8-Kneutralmateriality 5/10

06-01-2026

Skyward Specialty Insurance Group, Inc. filed an 8-K on 2026-01-06 (AccNo: 0001519449-26-000002, Size: 3 MB) announcing Item 1.01 Entry into a Material Definitive Agreement, Item 2.01 Completion of Acquisition or Disposition of Assets, Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. This indicates completion of a merger/acquisition event, but all specific deal structure, parties, valuation, consideration, synergies, regulatory details, and financial impacts are NOT_DISCLOSED.

GigCapital7 Corp.8-Kneutralmateriality 3/10

06-01-2026

GigCapital7 Corp. filed a Form 8-K on January 06, 2026 (AccNo: 0001193125-26-004729, Size: 11 MB), reporting an Other Event under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the event, transaction, or exhibits are disclosed in the provided filing summary. Sector is not specified.

Neuronetics, Inc.8-Kneutralmateriality 4/10

06-01-2026

Neuronetics, Inc. filed a Form 8-K on 2026-01-06 (AccNo: 0001193125-26-004728, Size: 133 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details including the officer's name, position, nature of change (appointment/resignation), reasons, or compensation are NOT_DISCLOSED. Sector is not specified.

BERKSHIRE HATHAWAY INC8-K/Aneutralmateriality 3/10

06-01-2026

Berkshire Hathaway Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004727, Size: 237 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or other quantitative data provided in the filing summary. Sector not specified.

Unknown8-Kneutralmateriality 1/10

06-01-2026

The company filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001398, Size: 207 KB), reporting Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No details on the specific events, financial statements, transactions, or any quantitative data are disclosed in the provided filing summary. This is a general filing with no explicit core event described.

Oncotelic Therapeutics, Inc.8-Kneutralmateriality 7/10

06-01-2026

Oncotelic Therapeutics, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000619, Size: 225 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant), along with Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, parties, transaction value, or financial terms are disclosed in the provided filing summary. This is a multi-item mandatory filing for material events.

Instil Bio, Inc.8-Kneutralmateriality 8/10

06-01-2026

Instil Bio, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001789769-26-000004, Size: 146 KB) disclosing under Item 1.02 the termination of a material definitive agreement. Sector not specified. No details on the agreement counterparties, value, financial impacts, or strategic rationale provided.

Laser Photonics Corp8-Kbearishmateriality 6/10

06-01-2026

Laser Photonics Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000629), reporting changes in its certifying accountant under Item 4.01 and financial statements and exhibits under Item 9.01. This is a multi-item mandatory disclosure with no details on the prior/new auditor, reasons for change, or quantitative impacts provided. Core event is the auditor change, a potential governance red flag.

MURPHY OIL CORP8-Kneutralmateriality 6/10

06-01-2026

Murphy Oil Corp filed a Form 8-K on January 6, 2026 (AccNo: 0000950103-26-000187, size 12 MB), reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing from the US SEC source, but specific details on transactions, financial metrics, dollar values, or impacts are NOT_DISCLOSED. Sector is not specified.

COMMUNITY FINANCIAL SYSTEM, INC.8-Kneutralmateriality 3/10

06-01-2026

COMMUNITY FINANCIAL SYSTEM, INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001402, size 203 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or individuals are provided. Sector is not specified.

Investar Holding Corp8-Kneutralmateriality 5/10

06-01-2026

Investar Holding Corp filed an 8-K on January 06, 2026 (AccNo: 0001437749-26-000650, Size: 183 KB), disclosing completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), departure/election of directors/officers or compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific parties, transaction value, deal structure, or financial metrics are disclosed in the provided filing summary. Sector is not specified.

INTERGROUP CORP8-Kneutralmateriality 3/10

06-01-2026

INTERGROUP CORP filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000636, Size: 219 KB), disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary. All quantitative data, named entities beyond the filer, and event specifics are NOT_DISCLOSED.

Safe & Green Development Corp8-Kneutralmateriality 7/10

06-01-2026

Safe & Green Development Corp filed a Form 8-K on January 06, 2026 (AccNo: 0001213900-26-001868, Size: 483 KB), reporting entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03. Item 9.01 includes Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties, or financial terms are disclosed in the provided information.

AMERICAN INTERNATIONAL GROUP, INC.8-Kneutralmateriality 3/10

06-01-2026

AMERICAN INTERNATIONAL GROUP, INC. disclosed an officer change via Form 8-K filed on 2026-01-06 (AccNo: 0000005272-26-000006, Size: 211 KB). Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 9.01 references Financial Statements and Exhibits; no specific details on positions, reasons, or names provided.

OneStream, Inc.8-Kneutralmateriality 6/10

06-01-2026

OneStream, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004772, Size: 1 MB), reporting multiple items: Item 1.01 (Entry into a Material Definitive Agreement), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details, transaction values, or financial metrics disclosed in the provided information. Sector not specified.

CareView Communications Inc8-Kneutralmateriality 6/10

06-01-2026

CareView Communications Inc filed a Form 8-K on 2026-01-06 (AccNo: 0001437749-26-000653, Size: 316 KB) reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No details on transaction parties, value, terms, or financial metrics are disclosed in the provided summary. Sector not specified.

Get daily alerts with 4 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 198 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
US SEC Filings Daily Market Digest β€” January 05, 2026 | Gunpowder Blog